nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ABCA4—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—CD36—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Risperidone—DRD1—GPCR ligand binding—CCL2—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RHO—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Risperidone—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Risperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Risperidone—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RHO—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Risperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Risperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Risperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—C3—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Risperidone—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.000985	0.000985	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00098	0.00098	CbGpPWpGaD
Risperidone—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00097	0.00097	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.000969	0.000969	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RHO—age related macular degeneration	0.000967	0.000967	CbGpPWpGaD
Risperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000966	0.000966	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.000949	0.000949	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00094	0.00094	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000936	0.000936	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.000931	0.000931	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—C3—age related macular degeneration	0.000912	0.000912	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.000906	0.000906	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—CCL2—age related macular degeneration	0.000906	0.000906	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—CCL2—age related macular degeneration	0.000891	0.000891	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.000887	0.000887	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.000887	0.000887	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000884	0.000884	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.000882	0.000882	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—C3—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TGFBR1—age related macular degeneration	0.00085	0.00085	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000844	0.000844	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000838	0.000838	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.000834	0.000834	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—C3—age related macular degeneration	0.000828	0.000828	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000827	0.000827	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.000823	0.000823	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000822	0.000822	CbGpPWpGaD
Risperidone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00082	0.00082	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFBR1—age related macular degeneration	0.000813	0.000813	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000809	0.000809	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—CCL2—age related macular degeneration	0.000807	0.000807	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.000806	0.000806	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—C3—age related macular degeneration	0.000793	0.000793	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.00079	0.00079	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—LIPC—age related macular degeneration	0.000786	0.000786	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—C3—age related macular degeneration	0.000786	0.000786	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SQSTM1—age related macular degeneration	0.00077	0.00077	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000765	0.000765	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—LIPC—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CETP—age related macular degeneration	0.000759	0.000759	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000757	0.000757	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000749	0.000749	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SQSTM1—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CETP—age related macular degeneration	0.000737	0.000737	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000736	0.000736	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000733	0.000733	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000732	0.000732	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000722	0.000722	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—C3—age related macular degeneration	0.000714	0.000714	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.000704	0.000704	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000704	0.000704	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.0007	0.0007	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000676	0.000676	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000673	0.000673	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000664	0.000664	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000655	0.000655	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—C3—age related macular degeneration	0.000654	0.000654	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—CCL2—age related macular degeneration	0.000648	0.000648	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000641	0.000641	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000637	0.000637	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000636	0.000636	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000631	0.000631	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00063	0.00063	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000626	0.000626	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.00062	0.00062	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000614	0.000614	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000611	0.000611	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000609	0.000609	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.0006	0.0006	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000599	0.000599	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.000594	0.000594	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000594	0.000594	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000592	0.000592	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000591	0.000591	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000585	0.000585	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000584	0.000584	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.000583	0.000583	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000572	0.000572	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000571	0.000571	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000568	0.000568	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000568	0.000568	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.000559	0.000559	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000557	0.000557	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000553	0.000553	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000552	0.000552	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000551	0.000551	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000544	0.000544	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000544	0.000544	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000543	0.000543	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000539	0.000539	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000533	0.000533	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000531	0.000531	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.00053	0.00053	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000529	0.000529	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.00052	0.00052	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000501	0.000501	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000495	0.000495	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000493	0.000493	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000492	0.000492	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—C3—age related macular degeneration	0.000489	0.000489	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000486	0.000486	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000483	0.000483	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000482	0.000482	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.00048	0.00048	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000478	0.000478	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000476	0.000476	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—C3—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000465	0.000465	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000457	0.000457	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CD36—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—APOE—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000453	0.000453	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000449	0.000449	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KDR—age related macular degeneration	0.000446	0.000446	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000434	0.000434	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000429	0.000429	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.000427	0.000427	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.000416	0.000416	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000416	0.000416	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000415	0.000415	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.000414	0.000414	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CETP—age related macular degeneration	0.000414	0.000414	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000404	0.000404	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—APOE—age related macular degeneration	0.000402	0.000402	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.000393	0.000393	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—APOE—age related macular degeneration	0.000391	0.000391	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CETP—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000387	0.000387	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CCL2—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.00038	0.00038	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.00038	0.00038	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000376	0.000376	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.000373	0.000373	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000367	0.000367	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000361	0.000361	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CD36—age related macular degeneration	0.00036	0.00036	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.000351	0.000351	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000343	0.000343	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000338	0.000338	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000336	0.000336	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.00033	0.00033	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CD36—age related macular degeneration	0.00033	0.00033	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.000327	0.000327	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000326	0.000326	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000322	0.000322	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.00032	0.00032	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000318	0.000318	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000317	0.000317	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000315	0.000315	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000307	0.000307	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000296	0.000296	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000292	0.000292	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000291	0.000291	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000291	0.000291	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.00029	0.00029	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000286	0.000286	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000285	0.000285	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000285	0.000285	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000284	0.000284	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.00028	0.00028	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000265	0.000265	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000264	0.000264	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000255	0.000255	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000249	0.000249	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CD36—age related macular degeneration	0.000249	0.000249	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000244	0.000244	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000239	0.000239	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000234	0.000234	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000225	0.000225	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000223	0.000223	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—age related macular degeneration	0.000219	0.000219	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000212	0.000212	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000209	0.000209	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000207	0.000207	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000189	0.000189	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000182	0.000182	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000181	0.000181	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000176	0.000176	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000174	0.000174	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.00016	0.00016	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000157	0.000157	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	0.000157	0.000157	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000154	0.000154	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000153	0.000153	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000143	0.000143	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000135	0.000135	CbGpPWpGaD
